Navigation Links
Viral curiosity spreads across continents
Date:4/22/2013

WHAT: Biologist Esteban Engel, Ph.D., was named by The Pew Charitable Trusts as the "Biomedical Researcher of the Month," for his innovative work in neurovirologythe study of viruses infecting the nervous system. As a postdoctoral researcher in the Princeton University laboratory of Lynn Enquist, Ph.D., Dr. Engel studies the spread of herpes simplex virus type 1 (HSV-1)which, in rare cases, can lead to blindness or lethal encephalitis.

Dr. Engel's story is part of a "Biomedical Researcher of the Month" series launched by Pew, and is the first to feature a Latin American fellow. Pew's Latin American fellows program gives individuals like Engel, who hails from Chile, an opportunity to further their scientific knowledge by promoting exchange and collaboration between investigators in the United States and Latin America. Since 1991, Pew's biomedical programs have provided funding to more than 200 young scientists from Latin America to receive postdoctoral training in the United States, resulting in advances that span continents.

WHO: Experts are available for interviews regarding Dr. Engel's research and the program:

  • Esteban Engel, Ph.D., postdoctoral fellow, Department of Molecular Biology, Princeton Neuroscience Institute, Princeton University
  • Anita Pepper, Ph.D., director of the Pew Programs in the Biomedical Sciences Pepper is the director of The Pew Charitable Trusts' biomedical programs, which include both the Latin American fellows and the Pew scholars program.

WHERE: Visit http://www.pewhealth.org/other-resource/Interview-with-Pew-Latin-American-Fellow-Esteban-Engel-85899469672 to read the full question-and-answer story, which covers both Dr. Engel's research and his motivation to conduct it in the United States.

CONTACT: Chelsea Toledo at 202-540-6846, ctoledo@pewtrusts.org


'/>"/>

Contact: Chelsea Toledo
ctoledo@pewtrusts.org
202-540-6846
Pew Health Group
Source:Eurekalert

Related biology news :

1. Recreational use of HIV antiretroviral drug linked to its psychoactivity
2. Antiviral lipid earns patent
3. Early antiretroviral treatment reduces viral reservoirs in HIV-infected teens
4. Study: Viral reactivation a likely link between stress and heart disease
5. Protein production: Going viral
6. Viral alliances overcoming plant defenses
7. New study shows promise in using RNA nanotechnology to treat cancers and viral infections
8. The physics of going viral
9. Vitamin D supplements may protect against viral infections during the winter
10. Women & Infants participating in study of treatment of common viral infection in pregnancy
11. Discovery offers insight into treating viral stomach flu
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/16/2016)... 2016   EyeLock LLC , a market leader ... of an IoT Center of Excellence in ... development of embedded iris biometric applications. EyeLock,s ... and security with unmatched biometric accuracy, making it the ... DNA. EyeLock,s platform uses video technology to deliver a ...
(Date:5/9/2016)... 9, 2016 Elevay is currently ... expanding freedom for high net worth professionals seeking travel ... globally connected world, there is still no substitute for ... duplicate sealing your deal with a firm handshake. This ... taking advantage of citizenship via investment programs like those ...
(Date:4/28/2016)... BANGALORE, India , April 28, 2016 ... of Infosys (NYSE: INFY ), and Samsung SDS, ... partnership that will provide end customers with a more ... payment services.      (Logo: http://photos.prnewswire.com/prnh/20130122/589162 ) ... financial services, but it also plays a fundamental part in ...
Breaking Biology News(10 mins):
(Date:6/27/2016)... (PRWEB) , ... June 27, 2016 , ... Parallel ... clinical trials, announced today the Clinical Reach Virtual Patient Encounter CONSULT module ... circle with the physician and clinical trial team. , Using the CONSULT module, patients ...
(Date:6/27/2016)... June 27, 2016  Liquid Biotech ... funding of a Sponsored Research Agreement with The ... cells (CTCs) from cancer patients.  The funding will ... levels correlate with clinical outcomes in cancer patients ... will then be employed to support the design ...
(Date:6/24/2016)... 24, 2016 Epic Sciences unveiled a ... susceptible to PARP inhibitors by targeting homologous recombination ... The new test has already been incorporated into ... cancer types. Over 230 clinical trials ... pathways, including PARP, ATM, ATR, DNA-PK and WEE-1. ...
(Date:6/23/2016)... ... June 23, 2016 , ... Mosio, ... second eBook, “Clinical Trials Patient Recruitment and Retention Tips.” Partnering with experienced clinical ... eBook by providing practical tips, tools, and strategies for clinical researchers. , “The ...
Breaking Biology Technology: